Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources. ow.ly/ifoS50QQun0

We need you! Join @Facingourrisk for its biggest advocacy event of the year! Meet virtually w/members of Congress and their staff to educate them about important issues faced by our high-risk community. ow.ly/95qg50QQuxt

Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources. ow.ly/ifoS50QQun0

We need you! Join @Facingourrisk for its biggest advocacy event of the year! Meet virtually w/members of Congress and their staff to educate them about important issues faced by our high-risk community. ow.ly/95qg50QQuxt

Donate #Bitcoin for a cause! Join @FacingOurRisk empowering those at risk of hereditary cancer. Donate BTC today and help further education, support and hope for people facing inherited cancers. #BTC #crypto #cancerawareness

Are you passionate about affordable access to high-risk health services? Join @Facingourrisk for its Virtual Advocacy Day on May 16. No experience needed. Your story is the most important component! We’ll provide training & resources. ow.ly/ifoS50QQun0

Empower those facing hereditary cancer risks! Donate cryptocurrency 🚀 to @FacingOurRisk and join the fight for awareness, education, and support. Together, we can make a difference. #crypto #donate #cancerawareness

🎉Debbie is our 2024 Teri Woodhull Empowerment Award winner! Her unwavering commitment to the hereditary cancer community is inspiring. Originally from Argentina, Debbie is dedicated to supporting Latino/a communities, bridging gaps in cancer care & research. Congrats, Debbie Denardi!

We spoke to Sue Friedman of @FacingOurRisk about the importance of linking patients to clinical trials. curetoday.com/view/more-is-n…

Men age 18+ with late stage prostate cancer may be eligible for a research study to learn the best dosage of radium and/or the PARP inhibitor Olaparib for treating castration resistant prostate cancer spread to the bones.

We're on #Instagram ! Go to @ facingourrisk to connect with FORCE, get updates about hereditary breast, ovarian and related cancers and to connect with others in the hereditary cancer community! ow.ly/ZrsL50O2LlF #FacingOurRisk #hereditarycancer

People w/ Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) stage IV CRC may be eligible 4 this study assessing the efficacy and safety of pembrolizumab/quavonlimab vs other treatments.

Women with a BRCA1 mutation ages 35-50 with an increased risk for ovarian cancer may enroll in the SOROCk study which looks at whether removal of fallopian tubes alone can lower ovarian cancer risk nearly as much as removing both the ovaries and fallopian tubes.

Neccesitamos su opinion.

The Inherited Cancer Registry (Inherited Cancer Registry (ICARE)) is conducting a #study focused on improving follow-up #care for those with #inheritedcancer #gene mutations. If you have an inherited cancer gene #mutation , consider enrolling at the following link: ow.ly/HwLZ50JuI6B

FORCE developed the Research Search and Enroll Tool Video to provide a reliable way for people w/inherited mutations to get matched w/hereditary cancer detection, prevention and treatment studies. This short video highlights the features of FORCE's Research Search and Enroll Tool

Women who carry the BRCA1, BRCA2 or PALB2 genetic mutation are needed for a study! Participants will be followed over time to build the evidence we need to help them make decisions to help reduce the risk of cancer. Interested? ow.ly/fYL950Q1UFm

Did you receive an unexpected genetic test result related to cancer risk? A new study is recruiting people who had genetic testing done for some other reason & received results related to their cancer risks.

Healthy diet & exercise may prevent colorectal cancer recurrence – Tools To Be Fit is a research study to figure out what is best in supporting cancer survivors who are trying to eat better & exercise more. To join or learn more visit: ow.ly/eP4x50I1Lr9

Research study testing vaccine for cancer prevention in BRCA1/2 mutation carriers. Goal is to reduce cancer risk. Study will test if vaccine is safe, test new way of giving vaccines and if vaccine activates immune system. ow.ly/Njih50PyWmC